Mustang Bio
(NASDAQ) MBIO
Mustang Bio Financials at a Glance
Market Cap
$5.48M
Revenue (TTM)
$0.00
Net Income (TTM)
$1.92M
EPS (TTM)
$-0.39
P/E Ratio
-1.85
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$0.75
Volume
18,861.987
Open
$0.74
Price
$0.75
Volume
18,861.987
Open
$0.74
Previous Close
$0.72
Daily Range
$0.71 - $0.76
52-Week Range
$0.53 - $7.00
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$0.75
Volume
18,861.987
Open
$0.74
Previous Close
$0.72
Daily Range
$0.71 - $0.76
52-Week Range
$0.53 - $7.00
MBIO News
MBIO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Mustang Bio
Industry
Biotechnology
Sector
Health CareEmployees
4
CEO
Manuel Litchman, MD
Website
www.mustangbio.comHeadquarters
Worcester, MA 01605, US
MBIO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-68%
Return on Capital
-25%
Return on Assets
-11%
Earnings Yield
-54.05%
Dividend Yield
0.00%
Payout Ratio
-14.21%
Stock Overview
Market Cap
$5.48M
Shares Outstanding
7.58M
Volume
18.86K
Short Interest
0.00%
Avg. Volume
175.92K
Financials (TTM)
Gross Profit
$41.00K
Operating Income
$2.43M
EBITDA
$2.39M
Operating Cash Flow
$5.26M
Capital Expenditure
$0.00
Free Cash Flow
$5.26M
Cash & ST Invst.
$17.27M
Total Debt
$0.00
Mustang Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$5.48M
N/A
Market Cap/Employee
$913.08K
N/A
Employees
6
N/A
Net Income
$538.00K
+43.5%
EBITDA
$670.00K
+23.5%
Quarterly Fundamentals
Net Cash
$17.27M
+189.6%
Accounts Receivable
$217.00K
-46.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-10.92%
N/A
Return on Invested Capital
-25.13%
N/A
Free Cash Flow
$1.72M
+14.0%
Operating Cash Flow
$1.72M
+14.0%